Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety—two sides of one coin?
Fabrício A. Moreira, Daniele C. Aguiar, Ana Luisa B. Terzian, et al.
Neuroscience (2011) Vol. 204, pp. 186-192
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 585
Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine
Bernd Nilius, A Szállaśi
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 676-814
Closed Access | Times Cited: 463
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz, Giovanni Marsicano, Rafaël Maldonado, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 12, pp. 705-718
Open Access | Times Cited: 422
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
Alejandro Aparisi Rey, Martin Purrio, María‐Paz Viveros, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 12, pp. 2624-2634
Open Access | Times Cited: 304
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
Sang‐Hoon Lee, Marco Ledri, Blanka Tóth, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 27, pp. 10039-10057
Open Access | Times Cited: 127
A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior
Ryan J. McLaughlin, Matthew N. Hill, Boris B. Gorzalka
Neuroscience & Biobehavioral Reviews (2014) Vol. 42, pp. 116-131
Closed Access | Times Cited: 123
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
Alvaro Llorente‐Berzal, Ana Luisa B. Terzian, Vincenzo Di Marzo, et al.
Psychopharmacology (2015) Vol. 232, Iss. 15, pp. 2811-2825
Closed Access | Times Cited: 97
Capsaicin: Physicochemical properties, cutaneous reactions and potential applications in painful and inflammatory conditions (Review)
Mihaela Ilie, Constantin Căruntu, Mircea Tampa, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 81
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 24
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 11
TRPs in the Brain
Rudi Vennekens, Aurélie Menigoz, Bernd Nilius
Springer eBooks (2012), pp. 27-64
Closed Access | Times Cited: 89
Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype
Luis A. Natividad, Matthew W. Buczynski, Melissa A. Herman, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. 500-510
Open Access | Times Cited: 70
Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment
John R. Richards, Jeff Lapoint, Guillermo Burillo–Putze
Clinical Toxicology (2017) Vol. 56, Iss. 1, pp. 15-24
Closed Access | Times Cited: 65
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Maria Morena, Andrei S. Nastase, Alessia Santori, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 4, pp. 983-996
Open Access | Times Cited: 63
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
W. Jacob, Rudolph Marsch, Giovanni Marsicano, et al.
Neurobiology of Learning and Memory (2012) Vol. 98, Iss. 1, pp. 47-55
Closed Access | Times Cited: 73
Temporal changes in N‐acylethanolamine content and metabolism throughout the peri‐adolescent period
Tiffany T.‐Y. Lee, Matthew N. Hill, Cecilia J. Hillard, et al.
Synapse (2012) Vol. 67, Iss. 1, pp. 4-10
Open Access | Times Cited: 63
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex‐dependent social interest in mice
Ana Luisa B. Terzian, Vincenzo Micale, Carsten T. Wotjak
European Journal of Neuroscience (2014) Vol. 40, Iss. 1, pp. 2293-2298
Closed Access | Times Cited: 61
Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels
Daniele C. Aguiar, Fabrício A. Moreira, Ana Luisa B. Terzian, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 418-428
Closed Access | Times Cited: 54
Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System
Sabrina F. Lisboa, Felipe V. Gomes, A. L. Silva, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 8, pp. pyv005-pyv005
Open Access | Times Cited: 53
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Tiffany T.-Y. Lee, Matthew N. Hill, Frank S. Lee
Genes Brain & Behavior (2015) Vol. 15, Iss. 1, pp. 108-124
Open Access | Times Cited: 53
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
Valéria de Almeida, Fernanda Fiel Peres, Raquel Levin, et al.
Schizophrenia Research (2014) Vol. 153, Iss. 1-3, pp. 150-159
Closed Access | Times Cited: 52
Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice
E.L. von Rüden, Renée Marie Bogdanović, Carsten T. Wotjak, et al.
Neurobiology of Disease (2015) Vol. 77, pp. 238-245
Closed Access | Times Cited: 50
Page 1 - Next Page

Scroll to top